Association of ischemia-modified albumin and melatonin in patients with ST-elevation myocardial infarction

Atherosclerosis

Volumn 199, Issue 1, 2008, Pages 73-78

  Dominguez Rodriguez, Alberto ^a   Abreu Gonzalez, Pedro ^b   Garcia Gonzalez, Martín J ^a   Samimi Fard, Sima ^a   Reiter, Russel J ^c   Kaski, Juan Carlos ^d  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Diurnal variation; Ischemia modified albumin; Melatonin; Reactive oxygen species; ST elevation myocardial infarction

Indexed keywords

ALBUMIN; MELATONIN;

ADULT; ANGIOPLASTY; ARTICLE; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MALE; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CIRCADIAN RHYTHM; ELECTROCARDIOGRAPHY; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; LINEAR MODELS; MALE; MELATONIN; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; REACTIVE OXYGEN SPECIES; RISK FACTORS; SERUM ALBUMIN;

EID: 45249103302     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.10.019     Document Type: Article

References (32)

1. Schachter M. The pathogenesis of atherosclerosis. Int J Cardiol 62 Suppl. 2 (1997) S3-S7
2. Morrow D.A., De Lemos J.A., Sabatine M.S., and Antman E.M. The search for a biomarker of cardiac ischemia. Clin Chem 49 (2003) 537-539
3. Marx G., and Chevion M. Site-specific modification of albumin by free radicals. Biochem J 236 (1985) 397-400
4. Gidenne S., Ceppa F., Fontan E., Perrier F., and Burnat P. Analytical performance of the Albumin Cobalt Binding (ACB) test on the cobas MIRA plus analyzer. Clin Chem Lab Med 42 (2004) 455-461
5. Roy D., Quiles J., Gaze D.C., et al. Role of reactive oxygen species on the formation of the novel diagnostic marker ischemia modified albumin. Heart 92 (2006) 113-114
6. Hardeland R., Balzer I., Poeggeler B., et al. On the primary function of melatonin in evolution: mediation of photoperiodic signals in a unicells, photoxidation and scavenging of free radicals. J Pineal Res 18 (1995) 104-111
7. Allegra M., Reiter R.J., Tan D.X., et al. The chemistry of melatonin's interaction with reactive species. J Pineal Res 34 (2003) 1-10
8. Reiter R.J. Melatonin: lowering the high price of free radicals. News Physiol Sci 15 (2000) 246-250
9. Van de Werf F., Ardissino D., Betriu A., et al. Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 24 (2003) 28-66
10. Reiter R.J. The melatonin rhythm: both a clock and calendar. Experientia 49 (1993) 654-664
11. Bhagavan N.V., Lai E.M., Rios P.A., et al. Evaluation of human albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 49 (2003) 581-585
12. Modification of Diet in Renal Disease Study Group, Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130 (1999) 461-470
13. Bar-Or D., Winkler J.V., VanBenthysen K., et al. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 141 (2001) 985-991
14. Sinha M.K., Gaze D.C., Tippins J.R., Collinson P.O., and Kaski J.C. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 107 (2003) 2403-2405
15. Quiles J., Roy D., Gaze D., et al. Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol 92 (2003) 322-324
16. Garrido I.P., Roy D., Calvino R., et al. Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without collaterals. Am J Cardiol 93 (2004) 88-90
17. Christenson R.H., Duh S.H., Sanhai W.R., et al. Characteristics of an albumin binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 47 (2001) 464-470
18. Sinha M., Roy D., Gaze D., Collinson P., and Kaski J.C. Role of "ischemia-modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 21 (2004) 29-34
19. Apple F.S., Quist H.E., Otto A.P., Mathews W.E., and Murakami M.M. Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem 48 (2002) 1097-1100
20. 2-isoprostane formation: evidence for in vivo oxidative stress during PTCA. J Am Coll Cardiol 37 (2001) 76-80
21. Lippi G., Montagnana M., and Guidi G.C. Albumin cobalt binding and ischemia modified albumin generation: an endogenous response to ischemia?. Int J Cardiol 108 (2006) 410-411
22. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia M.J., et al. Decreased nocturnal melatonin levels during acute myocardial infarction. J Pineal Res 33 (2002) 248-252
23. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M., et al. Elevated levels of oxidized low-density lipoprotein and impaired nocturnal synthesis of melatonin in patients with myocardial infarction. Atherosclerosis 180 (2005) 101-105
24. Reiter R.J., and Tan D.X. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 58 (2003) 10-19
25. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia M., et al. Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction. Cytokine 26 (2004) 89-93
26. Dominguez-Rodriguez A., Garcia-Gonzalez M., Abreu-Gonzalez P., Ferrer J., and Kaski J.C. Relation of nocturnal melatonin levels to C-reactive protein concentration in patients with ST-segment elevation myocardial infarction. Am J Cardiol 97 (2006) 10-12
27. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M.J., and Reiter R.J. Relation of nocturnal melaonin levels to serum matrix metalloproteinase-9 concentrations in patients with myocardial infarction. Thromb Res 120 (2007) 361-366
28. Tan D.X., Manchester L.C., Terron M.P., Flores L.J., and Reiter R.J. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?. J Pineal Res 42 (2007) 28-42
29. Reiter R.J., Tan D.X., Manchester L.C., and El-Sawi M.R. Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for aging. Ann N Y Acad Sci 959 (2002) 238-250
30. Leon J., Acuña-Castroviejo D., Sainz R.M., et al. Melatonin and mitochondrial function. Life Sci 75 (2004) 765-790
31. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M.J., Kaski J.C., and Reiter R.J. The melatonin adjunct in the acute myocardial infarction treated with primary angioplasty: study design and rationales (MARIA TRIAL). Atherosclerosis 7 Suppl. 3 (2006) 122
32. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M.J., et al. A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty. The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: study design and rationale. Contemp Clin Trials 28 (2007) 532-539